売上構成比はsix months ended June 28, 2026, high confidenceの推計であり、提出された報告書の数字ではありません。
DARZALEX
A medicine used to treat multiple myeloma, a cancer of plasma cells.
TREMFYA
A medicine for conditions including plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis.
CARVYKTI
A treatment made from a patient’s modified immune cells for multiple myeloma that has returned or has not responded to earlier treatment.
VARIPULSE
A system that uses pulsed electrical energy to treat atrial fibrillation, a disorder that causes an irregular heartbeat.
Impella
A heart pump used to support blood circulation in certain patients with heart failure or during high-risk heart procedures.
ACUVUE
A brand of contact lenses sold for vision correction.
Johnson & Johnson develops, makes and sells prescription medicines and medical devices around the world. Its two businesses are Innovative Medicine, which sells medicines for conditions including cancer and immune disorders, and MedTech, which sells products used in heart procedures, surgery, orthopaedics and vision care.
Johnson & Johnson 自身が米国証券取引委員会(SEC)に提出した書類にもとづきます。数字は報告されたままで、1 株当たりの履歴は今日の株数基準に修正済みです。 これは事業の説明です——投資助言ではなく、売買を勧めるものでもありません。
The themes Johnson & Johnson is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
InspectStocks 編集 · 20 companies
Surgical robots, implants, heart devices, glucose monitors and other medical equipment.
A 8B 7C 3D 2
InspectStocks 編集 · 13 companies
The largest drugmakers, selling prescription medicines worldwide.
A 7B 3C 3
$286.06+0.9%11月13日 終値
2026年9月27日までの数値(2026年10月21日提出の10-Qより)
Makes prescription medicines and medical devices for cancer, immune disorders, surgery, heart care, joint replacement and vision.
Grade A+
株価の下の帯は各日付時点の評価で、その時点までに公開された書類だけで算出しています。
Johnson & Johnson の評価履歴 41 四半期のうち 2 四半期を表示しています。 残る 39 四半期は 2016年11月 まで遡ります。